Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
4 In February 2026, the Department of Health and Human Services (HHS) announced a plan to reclassify approximately 14 of the 19 peptides previously restricted by the FDA in late 2023
Quality & Handling Prepared according to research-grade handling standards Batch verification processes applied Secure packaging designed to maintain compound integrity Certificate of Analysis available for review Technical Specifications Quantity: 10mg Format: Lyophilized powder Intended use: Laboratory research only Storage: Controlled conditions recommended Handling: Qualified personnel following laboratory protocols Shipping & Fulfillment Orders are processed through our fulfillment workflow and shipped securely from our US facility
Boston Medical Group takes a proactive, data-driven approach to ensure that PT-141 remains both safe and effective for each patient
Please consult a licensed healthcare provider before making any medical decisions
US$ 20.36
US$ 27.86
US$ 21.48
US$ 23.46
US$ 20.30
US$ 21.24
